Related by context. All words. (Click for frequent words.) 74 viraemia 73 antibody titers 69 HIV RNA 68 HBV DNA 68 seroconversion 67 CMV infection 67 NNRTI resistance 67 HBeAg seroconversion 67 serum HBV DNA 67 virologic failure 66 seropositivity 66 parasitaemia 66 antibody titer 65 neutralizing antibody 65 HBV DNA levels 65 transgene expression 65 plasma viremia 65 virological response 65 virologic response 65 viral loads 64 seroprevalence 64 serum testosterone 64 viral load 64 NNRTI resistant virus 64 HCV RNA 64 IFN gamma 64 titers 64 seronegative 64 antiviral efficacy 64 HCV genotype 64 coinfection 64 neutralizing antibodies 63 antibody responses 63 superinfection 63 chlamydial 63 viral suppression 63 fluoroquinolone resistance 63 maternal antibodies 63 alanine aminotransferase ALT 63 virologic 63 virologic responses 63 serum cortisol 63 HBeAg 63 parasitemia 63 viral titers 63 viremic 63 serum antibody 63 N. gonorrhoeae 63 serum concentrations 63 EBV infection 63 HPV-#/# 63 SIV infection 63 CD# upregulation 63 postvaccination 63 M#V mutation 62 CD4 + cell 62 plasma HCV RNA 62 immunocompetent 62 plasma concentrations 62 platelet reactivity 62 CMV disease 62 K#N 62 neutrophil counts 62 CD4 + cells 62 IgG antibody 62 herpesviruses 62 serum aminotransferase levels 62 serum ALT 62 HbF 62 H. influenzae 62 nephrotoxicity 62 HBsAg 62 seropositive patients 62 HBV infection 62 ALT flares 62 mg kg dose 62 enterococcal 62 chlamydial infection 62 transfusion transmitted 61 A. phagocytophilum 61 severe rotavirus gastroenteritis 61 pneumococci 61 hyperoxia 61 hematologic toxicity 61 serum IGF 61 CD8 responses 61 virological failure 61 C. trachomatis 61 AST ALT 61 corticosterone levels 61 undetectable HBV DNA 61 anemia hemoglobin 61 lymphocyte count 61 leukocytosis 61 reinfection 61 airway responsiveness 61 serogroup 61 lymphocyte counts 61 pH#N# 61 serum phosphate 61 IgM 61 enterovirus infection 61 bacteraemia 61 granulocyte 61 trophoblast cells 61 pegIFN 61 anti HBs 61 antiretroviral naive 61 lactate dehydrogenase 61 Plasmodium infection 61 Immunohistochemical analysis 61 hemoglobin Hb 61 IGFBP 3 61 titer 61 P aeruginosa 61 ALT normalization 61 sustained virologic response 61 HCV replicon 61 CD8 T cell 61 NAbs 60 hemoglobin concentrations 60 Bcl xL 60 immunological responses 60 biochemical relapse 60 seropositive 60 plasma cortisol 60 mutated KRAS 60 viral titer 60 HBV replication 60 transaminase elevations 60 serum urate levels 60 IFN beta 60 complete cytogenetic response 60 aminotransferase ALT 60 heterozygotes 60 serum phosphate levels 60 posttransplant 60 HCV infected 60 PBMCs 60 Plasmodium vivax 60 PCV2 60 aspartate aminotransferase 60 circulating lymphocytes 60 imatinib therapy 60 virus HBV 60 renal toxicity 60 inducible nitric oxide synthase 60 hemagglutination 60 systemic toxicity 60 H pylori 60 S. aureus infection 60 BALB c mice 60 R. equi 60 genotypic resistance 60 HCV genotypes 60 potent antiretroviral therapy 60 hepatitis C genotype 60 innate immune responses 60 seroprotection 60 adefovir 60 interferon γ 60 serum potassium 60 μmol L 60 IGFBP 60 μg ml 60 alpha1 60 rapid virological response 60 TNFalpha 60 serum calcium 60 lymphocytosis 60 virologically 60 alanine aminotransferase 60 low expressors 60 Immune responses 60 CMV infections 60 pyrazinamide 60 undetectable HCV RNA 60 fluconazole resistant 60 IgM antibodies 60 humoral responses 60 replicon 59 pneumococcal infection 59 vivax 59 PTLD 59 C. albicans 59 genital ulcers 59 ertapenem 59 ovarian hormones 59 hepatitis B infection 59 herpesvirus 59 glycated hemoglobin levels 59 serum creatinine levels 59 eosinophilia 59 plasma uric acid 59 detectable HCV RNA 59 Candida infection 59 Hb levels 59 timepoints 59 IFN alpha 59 serum antibodies 59 antimicrobial prophylaxis 59 K#R [002] 59 prothrombotic 59 TNF α 59 Candida species 59 resistant isolates 59 immunoreactivity 59 IgG antibodies 59 serum homocysteine 59 serum urate 59 posttreatment 59 piperacillin tazobactam 59 genotypic 59 log# 59 mRNA expression 59 serum uric acid 59 relapsed MM 59 S aureus 59 radiographic progression 59 subclinical 59 chloride secretion 59 plasma pharmacokinetics 59 platelet counts 59 chronic GVHD 59 undetectable viral loads 59 serum HCV RNA 59 immune reconstitution 59 BMPR2 59 IFN α 59 TP# mutations 59 HIV HCV coinfected 59 BVDV 59 caspofungin 59 genital ulcer disease 59 serum lipid levels 59 virologic suppression 59 NRTI resistance 59 S. aureus colonization 59 polioviruses 59 endotoxemia 59 Babesia 59 corticosteroid therapy 59 IL 1ß 59 sustained virological response 59 eotaxin 59 suppressive therapy 59 HER2 expression 59 CD4 + 59 tumor regressions 59 LTBI 59 GABHS 59 S. aureus isolates 59 seroconverted 59 trimethoprim sulfamethoxazole 59 tipranavir ritonavir 59 hemagglutination inhibition 59 cART 59 eosinophil count 59 androgen deprivation 59 transaminase levels 59 endometritis 59 nanomolar 59 lupus anticoagulant 59 log# reduction 59 C#BL 6 mice 59 neutralizing antibody responses 59 IgG4 58 multidrug resistance 58 recurrent genital herpes 58 troponin T 58 serum testosterone levels 58 thyrotropin 58 hyperbilirubinemia 58 neutrophil count 58 PASI scores 58 lactate dehydrogenase LDH 58 cytomegalovirus infection 58 IU mL 58 p# activation 58 airway hyperresponsiveness 58 coagulopathy 58 severe neutropenia 58 HCV genotype 1 58 colorectal carcinoma 58 CsA 58 serum sodium 58 undetectable hepatitis C 58 homozygotes 58 PSA nadir 58 immunosuppression 58 ovarian carcinoma 58 non progressors 58 hypoperfusion 58 BCG vaccinated 58 virologic breakthrough 58 IFN γ 58 recurrent UTI 58 H. pylori infection 58 B. burgdorferi 58 glomerular filtration 58 endogenous EPO 58 dose cyclophosphamide 58 fluoroquinolone resistant 58 viral kinetics 58 adrenalectomy 58 metastatic lesions 58 S/GSK# 58 serologically 58 ACTH 58 gametocytes 58 HAV infection 58 immunopathology 58 LCMV infection 58 FVIII 58 CCR5 tropic HIV 58 CCyR 58 pharmacokinetic interactions 58 undetectable viral load 58 nucleotide analog 58 blood glucose concentrations 58 GHRH 58 paraprotein 58 B7 H3 58 hypophosphatemia 58 liver histology 58 leukocyte count 58 serum IgG 58 WNV infection 58 mutant alleles 58 polymicrobial 58 protease inhibitors PIs 58 rifamycins 58 vaginal flora 58 copies mL 58 ESBLs 58 chronic HBV 58 posaconazole 58 CIN3 58 tuberculous 58 HSCT 58 CK # plasma concentrations 58 serologic 58 CLL cells 58 microfilariae 58 serum calcium levels 58 candidemia 58 HBeAg positive patients 58 serum retinol 58 QTcF 58 IgA deficiency 58 ZFN modified cells 58 PaO 2 58 aminotransferases 58 HBV genotype 58 bacteremic 58 intestinal permeability 58 imipenem 58 virologic failures 58 Neisseria meningitidis 58 thyroglobulin 58 gastric adenocarcinoma 58 nitrotyrosine 58 mg/m2 dose 58 antitumor efficacy 58 specific antigen PSA 58 HIV seroconversion 58 copies ml 58 haemolysis 58 glucocorticoid 58 evaluable subjects 58 pg ml 57 pDCs 57 GH secretion 57 prolonged QT interval 57 Plasmodium ovale 57 grade cervical intraepithelial 57 enteroviral 57 octreotide LAR 57 creatine kinase 57 Gag polymorphisms 57 elevated CRP 57 FLT3 57 IU ml 57 pheochromocytoma 57 Trichinella 57 immuno suppression 57 Mycoplasma pneumoniae 57 S. pneumoniae 57 definite stent thrombosis 57 serum potassium levels 57 vWF 57 micafungin 57 varicella infection 57 M. bovis 57 inhibin 57 hepatitis C virus 57 vesicoureteral reflux 57 HCV infection 57 iNOS 57 orchitis 57 node metastases 57 pg mL 57 cEVR 57 SSc patients 57 IgA antibodies 57 eradicate H. pylori 57 timepoint 57 locoregional disease 57 elevated ALT 57 S. enterica 57 Neutrophil 57 lopinavir 57 HBeAg negative patients 57 Aeromonas 57 urine NGAL 57 peripheral blood mononuclear 57 interferon IFN 57 cyclin E 57 E selectin 57 BARACLUDE ® 57 tyrosine phosphorylation 57 missense mutations 57 falciparum 57 PCa 57 Borrelia 57 germline mutation 57 MRSA colonization 57 DLTs 57 Asymptomatic 57 recurrent VTE 57 CFU ml 57 mcg dose 57 SGPT 57 acute GvHD 57 E. faecalis 57 tryptase 57 S. aureus infections 57 fosamprenavir 57 ADPKD 57 ADAMTS# 57 estrous cycle 57 somatostatin analogs 57 serum IgE 57 virulence genes 57 S. neurona 57 IFNg 57 hepatic glucose production 57 enteric bacteria 57 fructose diet 57 serum ferritin 57 inotropic 57 myocytes 57 Neisseria gonorrhoeae 57 hypoxemia 57 tuberculin skin testing 57 latently infected 57 invasive aspergillosis 57 immunized mice 57 IUGR 57 demyelinating 57 peginterferon 57 MRSA isolates 57 steroid dexamethasone 57 Vacc 4x 57 Bacteroides 57 solithromycin 57 coagulase negative staphylococci 57 mutant p# 57 entecavir 57 Cmax 57 K ras mutations 57 hemorrhagic complications 57 basal cell nevus syndrome 57 rFVIIa 57 UGT#A# * 57 Herpes virus 57 combination antiretroviral therapy 57 undetectable viral 57 serologic testing 57 urate levels 57 intracranial hemorrhage ICH 57 karyotypes 57 indinavir 57 APTIVUS r 57 S. Typhimurium 57 Yersinia enterocolitica 57 human chorionic gonadotropin hCG 57 activin 57 gonadotropins 57 endometrial carcinoma 57 transaminases 57 asymptomatic carriers 57 microsatellite instability 57 haematological toxicity 57 VZV 57 rapid virologic response 57 HBeAg negative 57 cortisol secretion 57 genital herpes infections 57 oxytetracycline 57 serogroup C 57 dose cohort 57 hepatic enzymes 57 serum phosphorus levels 57 ALT elevation 57 bacteriuria 57 cytotoxicity 57 plasma leptin 57 nucleoside analogues 57 NRTI 57 microglial activation 57 SSc 57 hemolytic 57 PTPN# 57 nucleoside naive patients 57 tumor regression 57 thrombotic complications 57 RSV replication 57 microglial 57 autoantibody levels 57 antiviral potency 57 vaccinees 57 oestradiol 57 effector function 57 serum BDNF 57 acromegalic patients 57 nmol liter 57 elevated creatinine 56 titres 56 thrombocytopenic 56 mtDNA mutations 56 sUA 56 intensive statin therapy 56 blood phenylalanine Phe 56 simian foamy virus 56 receptor blocker 56 HLA B 56 glycemia 56 granulocytes 56 TMC# r 56 CD4 + T 56 4CMenB 56 biochemical recurrence 56 serum albumin 56 monocyte 56 dsDNA 56 sCD# 56 HbA 1c levels 56 intravascular hemolysis 56 COPD exacerbations 56 endophthalmitis 56 Clostridium difficile infections 56 TIMP 56 lymphoproliferative disorder 56 genital tract 56 vasogenic edema 56 PDGFR 56 intermittent hypoxia 56 cholestasis 56 immunodeficient 56 HBeAg positive 56 REYATAZ r arm 56 interferon gamma 56 rotaviruses 56 Enterococci 56 CD4 counts 56 mucosal immunity 56 C. perfringens 56 nelfinavir 56 CD# expression [001] 56 coexpression 56 lamivudine resistant 56 IgA 56 intramuscularly 56 NNRTIs 56 antigen PSA levels 56 Chlamydia trachomatis 56 macroalbuminuria 56 quinolone resistant 56 locomotor activity 56 cTnT 56 Plasmodium parasites 56 bacterial pneumonias 56 corticosteroid dose 56 leukemic cell 56 antibody titres 56 thyroid carcinoma 56 Hb A1C 56 antiviral activity 56 plasma glucose 56 empyema 56 Enterobacter cloacae 56 μg dL 56 pyelonephritis 56 aminotransferase levels 56 pressor response 56 clostridial diseases 56 locoregional 56 follicle stimulating hormone FSH 56 cervical vaginal 56 inflammatory biomarkers 56 DAS# CRP 56 coinfected 56 HCV replication 56 S. typhimurium 56 mcg mL 56 NKT cell 56 causative organism 56 renal allograft 56 FasL 56 serum PTH 56 PSADT 56 palivizumab 56 antiviral therapy 56 salmonellae 56 HPV subtypes 56 adrenocorticotropic hormone 56 airway hyper responsiveness 56 cortisol concentrations 56 herpes infection 56 germline mutations 56 sulfasalazine 56 log# copies mL 56 pneumocystis 56 C. diff infections 56 prostate cancer CaP 56 mediated immunity 56 Viral load 56 haematopoietic 56 neurologic symptoms 56 albicans 56 thyroid stimulating hormone 56 androgen suppression 56 procalcitonin 56 chorioamnionitis 56 N. meningitidis 56 cAMP 56 Replikin 56 IL#B 56 Pneumocystis carinii pneumonia 56 EpCAM expression 56 urothelial carcinoma 56 pulmonary exacerbations 56 overt hypothyroidism 56 CR nPR 56 serum phosphorus 56 EXJADE 56 plasma kallikrein 56 CRBSI 56 cynomolgus monkeys 56 liver transplant recipients 56 endometrial hyperplasia 56 Chlamydia infections 56 elevated LDH 56 L. monocytogenes 56 NPY expression 56 endothelial activation 56 thioredoxin 56 prion strains 56 CAG repeats 56 progression TTP 56 vancomycin resistant 56 papillomas 56 tumor recurrence 56 HI titers 56 serum leptin 56 linezolid resistant 56 uninfected mice 56 amoxicillin clavulanate 56 neutropaenia 56 amenorrhoea 56 mediastinitis 56 B. fragilis 56 genotype 56 AZT zidovudine Retrovir 56 CD8 + T 56 P. aeruginosa 56 lymphoid organs 56 Varicella zoster virus 56 potentiation 56 Salmonella spp 56 griseofulvin 56 virological suppression 56 liver transaminases 56 albuminuria 56 cranial irradiation 56 thromboembolic events 56 TTR gene 56 T2 lesions 56 cholangiocarcinoma 56 mucosal healing 56 genotypes 56 % CI #.#-#.# [007] 56 genotype 1b 56 Lp PLA 2 56 prion infection 56 FOLPI 56 cerebral ischemia 56 hepatocellular carcinomas 56 heterozygous 56 virions 56 HIV uninfected 56 sublethal 56 PCV7 vaccine 56 precancerous cervical lesions 56 Epstein Barr virus EBV 56 retransplantation 56 tHcy 56 cytopathic 56 immunodeficiency 56 BRSV 56 atheroma volume 56 urethritis 56 P. acnes 56 VUR 56 Salmonella typhi 56 outcrossing 56 MGUS 56 eosinophilic 56 infectivity 56 serum TSH 56 ALT elevations 56 H#K#me# 56 splenocytes 56 concomitant antibiotics 56 deleterious mutations 56 clinically asymptomatic 56 soluble endoglin 56 TT genotype 56 C. neoformans 56 CHIKV 56 methicillin susceptible Staphylococcus aureus 56 bactericidal activity 56 alkaline phosphatase ALP 56 M. genitalium 56 hepatic insulin sensitivity 56 p = #.# [003] 56 COPD exacerbation 56 bronchopulmonary dysplasia 56 latent tuberculosis infection 56 leucopenia 56 ABCB1 56 epithelial barrier 55 allogeneic transplantation 55 Replikin Count 55 colorectal adenoma 55 CIN2 + 55 genital ulcer 55 CEACAM1 55 thromboembolic complications 55 IgG1 55 virological 55 allograft rejection 55 hyperalgesia 55 uPA 55 hemodilution 55 M. leprae 55 systemic corticosteroids 55 hypercalcemia 55 hydroxyvitamin D levels 55 sCJD 55 μg dl 55 mIU ml 55 Inhibin B 55 anti Xa 55 HCV viral 55 expressors 55 multidrug resistant 55 Enterobacteriaceae 55 ribavirin therapy 55 tumorigenicity 55 receptor binding 55 hemoglobin concentration 55 S. aureus 55 FMDV 55 SHANK3 55 mammary tumors 55 P = .# 55 HBV vaccine 55 anti dsDNA antibodies 55 HPV# 55 LPV r 55 CD8 T 55 nosocomial infection 55 hepatic fibrosis 55 clostridial 55 trichomonas 55 xenograft tumors 55 squamous intraepithelial lesions 55 Chlamydia trachomatis infection 55 urinary calcium 55 bleomycin 55 LPS induced 55 carcinoids 55 Serum creatinine 55 SHBG levels 55 etiological agent 55 antibiotic susceptibility 55 fibrin deposition 55 iPTH 55 serum PSA 55 Poliovirus 55 antibody mediated 55 homozygote 55 Trichomonas vaginalis 55 cerebral vasospasm 55 serum vitamin D 55 T. vaginalis 55 intracellular bacteria 55 R0 resection 55 transgenic rats 55 bacterium Neisseria meningitidis 55 IL 1β 55 immunostaining 55 L. pneumophila 55 bacteremia 55 Replikin Count TM 55 tumor xenograft models 55 immunologic responses 55 DFMO 55 immunosuppressed patients 55 HSV1 55 colorectal tumor 55 Partial Responses 55 low dose ritonavir 55 Anaplasma phagocytophilum 55 amprenavir 55 transdermal estradiol 55 opportunistic pathogens 55 decitabine 55 autoantibody 55 % CI #.#-#.# [003] 55 suppressor cells 55 stress hormone corticosterone 55 distant metastases 55 gonococcal infections 55 M. catarrhalis 55 pneumococcal carriage 55 antibody secreting cells 55 serum estradiol 55 variant alleles 55 OAB symptoms 55 nocturnal hypoglycaemia 55 leukemic stem cells 55 PAOD 55 experienced virologic failure 55 chronic HCV infection 55 precursor lesions 55 unboosted 55 Prox1 55 mycobacterial 55 pituitary hormone 55 heavily pretreated 55 CD8 T cells 55 ng dL 55 mycophenolate mofetil MMF 55 EGFRvIII 55 CD4 cell 55 CD4 lymphocyte count 55 GPx 55 P falciparum 55 obstructive coronary artery 55 pertussis toxin 55 Notch1 55 PEG IFN 55 pCR 55 neointimal hyperplasia 55 myeloperoxidase 55 human herpesvirus 55 antithymocyte globulin 55 fetal malformations 55 cytomegalovirus CMV 55 neutropenic 55 nucleotide substitutions 55 penetrance 55 intact parathyroid hormone 55 FXIII 55 Leydig cell 55 oral FTY# 55 triiodothyronine 55 spontaneous preterm delivery 55 follicular fluid 55 etiologic agent 55 induced sputum 55 CrCl 55 seroprotective 55 leukemic cells 55 CD4 T 55 immune responses 55 mycophenolate mofetil 55 mycobacterial infection 55 systolic dysfunction 55 advanced adenoma 55 8 OHdG 55 P. falciparum 55 thromboembolism 55 Heterozygous 55 Ad5 immunity 55 Streptococcus pyogenes 55 cytoreduction 55 HMPV 55 nonvaccine 55 prostate carcinoma 55 serum LDL cholesterol 55 Bcr Abl mutations 55 p = NS 55 IgG2 55 HAART 55 outer membrane proteins 55 Leydig cells 55 PON1 enzyme 55 sputum cultures 55 pT3 55 mammary gland tumors 55 EGFR receptor 55 IFN ß 55 PlGF 55 sweat chloride 55 nucleoside naive 55 antibiotic prophylaxis 55 atherogenic dyslipidemia 55 favorable pharmacokinetic profile 55 chronic hepatitis cirrhosis 55 radezolid 55 dose ritonavir 55 pharmacodynamic 55 perioperative complications 55 neutropenic fever 55 Candida glabrata 55 leukocyte 55 pneumoniae 55 multivariable analysis 55 serotype #A 55 histologically 55 CDAD 55 invasive meningococcal disease 55 CLA supplementation 55 defensin 55 rheumatoid factor 55 selenium supplementation 55 pretest probability 55 tigecycline 55 CD4s 55 fasting glucose levels 55 SVR# 55 postexposure 55 wild poliovirus 55 oocyst 55 bivalent 55 persisters 55 uM 55 lymph node metastasis 55 streptococcal 55 HepG2 cells 55 APTIVUS 55 microscopic hematuria 55 rhGH 55 peg interferon 55 ASCUS 55 serum creatinine 55 CC genotype 55 cytomegalovirus 55 gonococcal 55 cathepsin B 55 IgG 55 hepatoma 55 acetabular dysplasia 55 S. pyogenes 55 complete cytogenetic 55 isoenzyme 55 C. pneumoniae 55 IOP lowering 55 cidofovir 55 interstitial pneumonia 55 quadrivalent vaccine 55 bFGF 55 isoproterenol 55 glomerular 55 pmol L 55 GIST tumors 55 mTOR inhibitors 55 Helicobacter 55 gene rearrangements 55 susceptible isolates 55 anti leukemic 55 murine 55 ischemic lesions 55 genital HSV 55 cells μL 55 umbilical vein 55 renal cell carcinomas 55 valacyclovir 55 Respiratory Syncytial Virus RSV 55 etiologic 55 fig. S2 55 plasma folate 55 motoneurons 55 latently infected cells 55 renal tubular